Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections-Reference-Cited by-同舟云学术

Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections

Published:2019-10 Issue:4-5 Volume:67 Page:398-407
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Zhang Yue,Guo Xiaonan,Guo Mengze,Chen Xiaorui,Li Bo,Yu Jinfei,Gu Tiejun,Kong Wei,Wu Yongge^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-019-09107-6.pdf

Reference50 articles.

1. Mitchell TJ. Streptococcus pneumoniae: infection, inflammation and disease. Adv Exp Med Biol. 2006;582:111–24.

2. Zhanel GG, Wolter KD, Karlowsky JA. Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of phase 3 clinical trial data-authors' response. J Antimicrob Chemother. 2015;70:3170–1.

3. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, Group WHOCHER. WHO estimates of the causes of death in children. Lancet. 2005;365:1147–52.

4. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902.

5. Mera R, Miller LA, Fritsche TR, Jones RN. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist. 2008;14:101–7.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel bacterium-like particles platform displaying antigens by new anchoring proteins induces efficacious immune responses;Frontiers in Microbiology;2024-05-22

2. Mucosal vaccines for viral diseases: Status and prospects;Virology;2024-05

3. Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines;Vaccines;2024-04-12

4. Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant;Expert Review of Vaccines;2024-04-02

5. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters;Journal of Virology;2024-02-20